Cargando…

Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

The blood–brain barrier (BBB) is a highly selective and restrictive semipermeable network of cells and blood vessel constituents. All components of the neurovascular unit give to the BBB its crucial and protective function, i.e., to regulate homeostasis in the central nervous system (CNS) by removin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Rihani, Sweilem B., Darakjian, Lucy I., Deodhar, Malavika, Dow, Pamela, Turgeon, Jacques, Michaud, Veronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038419/ https://www.ncbi.nlm.nih.gov/pubmed/33916769 http://dx.doi.org/10.3390/ijms22073742

Ejemplares similares

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
por: Deodhar, Malavika, et al.
Publicado: (2020)

Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
por: Deodhar, Malavika, et al.
Publicado: (2021)

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models
por: Al Rihani, Sweilem B., et al.
Publicado: (2021)

ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
por: Michaud, Veronique, et al.
Publicado: (2020)

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs
por: Michaud, Veronique, et al.
Publicado: (2020)

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
por: Al Rihani, Sweilem B., et al.
Publicado: (2020)

Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study
por: Smith, Matt K., et al.
Publicado: (2021)

Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity
por: Darakjian, Lucy, et al.
Publicado: (2021)

Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare Costs
por: Michaud, Veronique, et al.
Publicado: (2021)

The Blood–Brain Barrier in Health and Disease
por: Al Rihani, Sweilem B., et al.
Publicado: (2023)

Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
por: Deodhar, Malavika, et al.
Publicado: (2021)

Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly
por: Ha, Meghan, et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition
por: Long, Tao, et al.
Publicado: (2021)

A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human Duodenum
por: Gravel, Sophie, et al.
Publicado: (2019)

Drug Transport and Metabolism in the Blood–Brain Barrier
por: Kapitulnik, Jaime
Publicado: (2011)

Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
por: Han, Liang
Publicado: (2021)

Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues
por: Maximos, Sarah, et al.
Publicado: (2017)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021)

Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition
por: Parvez, Md Masud, et al.
Publicado: (2023)

Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism
por: Michaud, Veronique, et al.
Publicado: (2010)

Sex Differences in Blood–Brain Barrier Transport of Psychotropic Drugs
por: Dalla, Christina, et al.
Publicado: (2022)

Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles
por: Meairs, Stephen
Publicado: (2015)

Developmental patterns in human blood–brain barrier and blood–cerebrospinal fluid barrier ABC drug transporter expression
por: Verscheijden, L. F. M., et al.
Publicado: (2020)

Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
por: Luo, Huilong, et al.
Publicado: (2020)

Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells
por: Leung, Yat Hei, et al.
Publicado: (2017)

Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
por: Fenneteau, Frédérique, et al.
Publicado: (2009)

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
por: Batarseh, Yazan S., et al.
Publicado: (2016)

Plasticity of Carbohydrate Transport at the Blood-Brain Barrier
por: McMullen, Ellen, et al.
Publicado: (2021)

Roles of Drug Transporters in Blood-Retinal Barrier
por: Liu, Li, et al.
Publicado: (2019)

Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity
por: Yang, Junzhi, et al.
Publicado: (2018)

Brain-transportable dipeptides across the blood-brain barrier in mice
por: Tanaka, Mitsuru, et al.
Publicado: (2019)

Transporter protein and drug-conjugated gold nanoparticles capable of bypassing the blood-brain barrier
por: Zhang, Yanhua, et al.
Publicado: (2016)

Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters
por: Tun, Temdara, et al.
Publicado: (2017)

Precision medication: An illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics
por: Bain, Kevin T., et al.
Publicado: (2019)

Transport of Amino Acids Across the Blood-Brain Barrier
por: Zaragozá, Rosa
Publicado: (2020)

Functional Expression of Choline Transporters in the Blood–Brain Barrier
por: Inazu, Masato
Publicado: (2019)

Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases
por: Blethen, Kathryn E, et al.
Publicado: (2021)

Transport Rankings of Non-Steroidal Antiinflammatory Drugs across Blood-Brain Barrier In Vitro Models
por: Novakova, Iveta, et al.
Publicado: (2014)

Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier
por: Luptáková, Dominika, et al.
Publicado: (2021)

Blood-brain barrier transport machineries and targeted therapy of brain diseases
por: Barar, Jaleh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jspjh9jav429pdalq47o87el2v